Results 11 to 20 of about 69,470 (266)

Time to switch from CLSI to EUCAST? A Southeast Asian perspective [PDF]

Clinical Microbiology and Infection, 2019
Despite the importance of antimicrobial susceptibility testing (AST) to clinical management of infection and to antimicrobial resistance (AMR) surveillance, methodologies and breakpoints of the two most commonly used systems worldwide, CLSI and EUCAST, are far from harmonized.
Cusack, T, Ashley, E, Ling, C, Roberts, T, Turner, P, Wangrangsimakul, T, Dance, D   +6 more
openaire   +4 more sources

Estudo comparativo entre as metodologias preconizadas pelo CLSI e pelo EUCAST para avaliação da atividade antifúngica Comparative study of the recommended methodologies by CLSI and EUCAST for activity evaluation antifungal

Química Nova, 2009
The international organizations CLSI and EUCAST developed reference methodologies for activity evaluation antifungal. The aim of this work was to compare the recommended methodologies by the CLSI and EUCAST in the antifungal activity evaluation of crude ...
Marcos Aurélio Stoppa, Luciana Assirati Casemiro, Adriana Helena Chicharo Vinholis, Wilson Roberto Cunha, Márcio Luis Andrade e Silva, Carlos Henrique Gomes Martins, Niege Araçari Jacometti Cardoso Furtado   +6 more
doaj   +2 more sources

Uptake of Revised CLSI Breakpoints and Potential Impact among Hospitals Reporting to The NHSN AR Option, 2022

Antimicrobial Stewardship & Healthcare Epidemiology
Background: Antimicrobial susceptibility testing (AST) is critical for detecting antimicrobial resistance (AR) and guiding antimicrobial treatment. The Clinical and Laboratory Standards Institute (CLSI) regularly publishes and revises breakpoints to ...
Allan Nkwata, Rupert England, Laura Blum, Hsiu Wu   +3 more
doaj   +2 more sources

bloodstream isolates applying EUCAST over CLSI breakpoints

, 2023
BackgroundCefiderocol is generally active against carbapenem-resistant Klebsiella spp. (CRK) with higher MICs against metallo-beta-lactamase producers. There is a variation in cefiderocol interpretive criteria determined by EUCAST and CLSI. Our objective
Michelle J. Bauer, Özlem Azap, Menekşe, Şirin, Akalin, Halis, Önder Ergönül, Şimsek, Funda, Mehtap Aydın, Bauer, Michelle J. J., David L. Paterson, Keşke, Siran, Akova, Murat, Can, Füsun, Çınar, Güle, Brian Forde, Hamiyet Demirkaya, Aslan, Abdullah Tarik, Gülşen Hazırolan, Murat Akova, Balkan, Ilker Inanç, Doğan, Özlem, Gönen, Mehmet, Mahir Kapmaz, Yağcı, Serap, İşler, Burcu, Abdullah Tarık Aslan, Bauer, Michelle J., Serap Yağcı, Çiğdem Arabacı, Kapmaz, Mahir, Saltoğlu, Neşe, Füsun Can, Alpay Azap, Azap, Ozlem, Demir, Safiye Koçulu, Arabacı, Ciğdem, Azap, Alpay, Elif Tükenmez Tigen, İlker İnanç Balkan, Harris, Patrick N. A., Funda Şimşek, Veli Oğuzalp Bakır, Berna Özer, Paterson, David L. L., ÇINAR, GÜLE, Aydın, Mehtap, Tigen, Elif Tükenmez, Bakir, Veli Oguzalp, Özer, Berna, Forde, Brian, Demirkaya, Hamiyet, Ergönül, Önder, Şirin Menekşe, Şiran Keske, Paterson, David L., Bakır, Veli Oğuzalp, Doğan,Özlem, Necla Tülek, Burcu Isler, Cansel Vatansever, Patrick N. A. Harris, Güle Çınar, Vatansever, Cansel, Tülek, Necla, Halis Akalin, Özlem Doğan, Safiye Koçulu Demir, Neşe Saltoğlu, Caitlin Falconer, Mehmet Gönen, Falconer, Caitlin, Hazırolan, Gülşen   +70 more
core   +2 more sources

In Vitro Pharmacokinetic/Pharmacodynamic Modeling of Voriconazole Activity against Aspergillus Species in a New In Vitro Dynamic Model [PDF]

, 2012
The pharmacodynamics (PD) of voriconazole activity against Aspergillus spp. were studied using a new in vitro dynamic model simulating voriconazole human pharmacokinetics (PK), and the PK-PD data were bridged with human drug exposure to assess the ...
Zerva, Loukia, Meletiadis, Joseph, Velegraki, Aristea, Elefanti, Antigoni, Al Saigh, Rafal   +4 more
core   +1 more source

Application of the latest CLSI EP guidelines in light-initiated chemiluminescent assay for testosterone [PDF]

Journal of Medical Biochemistry
Background: A commercial light-initiated chemiluminescent assay (LiCA) for testosterone (T) measurement was developed. This study comprehensively evaluated the analytical performance of LiCA-T following the Clinical and Laboratory Standards Institute ...
Liang Ai, Xiao-Jing Cao, Xin-Xin Ren, Lan Kang, Dan Zhang, Chang Xin   +5 more
doaj   +1 more source

Epitaxially grown silicon-based single-atom catalyst for visible-light-driven syngas production

Nature Communications, 2023
Despite the natural abundance and promising properties of Si, there are few examples of crystalline Si-based catalysts. Here, the authors report an epitaxial growth method to construct Co single atoms on Si for light driven CO2 reduction to syngas.
Huai Chen, Yangyang Xiong, Jun Li, Jehad Abed, Da Wang, Adrián Pedrazo-Tardajos, Yueping Cao, Yiting Zhang, Ying Wang, Mohsen Shakouri, Qunfeng Xiao, Yongfeng Hu, Sara Bals, Edward H. Sargent, Cheng-Yong Su, Zhenyu Yang   +15 more
doaj   +1 more source

In vitro activity of ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in the Middle East and Africa: AWARE global surveillance programme 2015–2018

Journal of Global Antimicrobial Resistance, 2021
Objectives: To report antimicrobial susceptibility testing surveillance data for ceftaroline and comparative agents from the AWARE global surveillance programme for bacterial pathogens causing skin and soft tissue infections (SSTIs) and lower respiratory
James A. Karlowsky, Meredith A. Hackel, Samue l K. Bouchillon, Warren Lowman, Ramy El Mahdy Kotb, Naglaa Mohamed, Gregory G. Stone, Daniel F. Sahm   +7 more
doaj   +1 more source

The AST interpretation chart (extracted from CLSI, guideline 2020).

, 2022
Based on CLSI criteria, interpret the zones sizes of each antimicrobial, reporting the organism as ‘Resistant’, ‘Intermediate/Moderately susceptible’, ‘Susceptible see below the table’. (RTF)
Desie Kasew (10186174), Feleke Moges (4091917), Azanaw Amare (6589409), Setegn Eshetie (4091920)   +3 more
core   +1 more source

Implementing the Updated Guidelines in Routine Clinical Microbiology Reporting [Letter]

Infection and Drug Resistance, 2022
Ketaki Niranjan Pathak, Sourav Sen Department of Microbiology, Symbiosis Medical College for Women (SMCW), Symbiosis International (Deemed University) (SIU), Pune, Maharashtra, IndiaCorrespondence: Ketaki Niranjan Pathak, Department of Microbiology ...
Pathak KN, Sen S
doaj